Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Sygnis

Sygnis
2008 FOUNDED
PUBLIC STATUS
11-20 EMPLOYEES
LIOK STOCK SYMBOL
2 INVESTMENTS
Description

Developer of products designed to replicate DNA. The company is involved in the identification of new polymerases and development and exploitation of polymerase applications for the sequencing, repair and amplification of DNA and the development of biomarkers for diagnostic and therapeutic uses.

Website
Formerly Known As
X-Pol Biotech
Ownership Status
Publicly Held
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Commercial Services
Other Industries
Other Pharmaceuticals and Biotechnology
Biotechnology
Stock Exchange
ETR
Primary Office
  • Waldhofer Street 104
  • 69123 Heidelberg
  • Germany

+49 03491 0000000

Sygnis Financials Summary

In Thousands,
USD
TTM
31-Dec-2018
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Revenue 16,940 16,940 8,901 2,092
Total Assets 73,412 73,412 59,952 40,009
Total Debt 0 0 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Sygnis Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Sygnis‘s full profile, request access.

Request full access to PitchBook

Sygnis Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 06-Apr-2018 000000000000000000 000.00 Biotechnology 00000 00 00 000000
C.B.S. Scientific Company 01-Jan-2017 Merger/Acquisition 00000 Other Devices and Supplies 00000 00 00 000000
To view this company’s complete investment and acquisition history, request access »

Sygnis Subsidiaries (2)

Company Name Industry Location Founded
Expedeon Biotechnology San Diego, CA 1997
0.0.0. 0000000000 Other Devices and Supplies San Diego, CA 0000
To view this company’s complete subsidiary history, request access »

Sygnis Executive Team (7)

Name Title Board
Seat
Contact
Info
Heikki Lanckriet Ph.D Chief Executive Officer & Chief Scientific Officer
David Roth Chief Financial Officer
Nick Gee Chief Technology Officer
Luis Blanco Dávila Co-Founder & Advisor
Margarita Salas Co-Founder & Advisor

2 Former Executives

You’re viewing 5 of 7 executives. Get the full list »